Dendritic cell-based therapeutics for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications[Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro]
/in Chronic Virus Hepatitis, International PublicationsDendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives
/in Colorectal Cancer, Dendritic Cells, International PublicationsOverview of phase I studies of intravenous administration of PV701, an oncolytic virus
/in International Publications, Newcastle Disease VirusDendritic cell-based immunotherapy in multiple myeloma
/in Dendritic Cells, International Publications, Malignant Lymphoma, Multiple MyelomaClinical significance of immune cell infiltration within gallbladder cancer
/in Gallbladder Cancer, International PublicationsWhole body thermochemotherapy in an infant with rhabdomyosarcoma and pulmonary metastases
/in International Publications, NSCLCImmunobiology and gene-based immunotherapy of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International PublicationsAn approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors
/in Hyperthermia, International Publications, Soft Tissue Sarcoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer